Haycock JW - Search Results

1

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users.

Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ. Wilson JM, et al. Among authors: haycock jw. Nat Med. 1996 Jun;2(6):699-703. doi: 10.1038/nm0696-699. Nat Med. 1996. PMID: 8640565

2

Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy.

Zhong XH, Haycock JW, Shannak K, Robitaille Y, Fratkin J, Koeppen AH, Hornykiewicz O, Kish SJ. Zhong XH, et al. Among authors: haycock jw. Mov Disord. 1995 Jan;10(1):10-7. doi: 10.1002/mds.870100104. Mov Disord. 1995. PMID: 7885342

3

Striatal dopaminergic and serotonergic markers in human heroin users.

Kish SJ, Kalasinsky KS, Derkach P, Schmunk GA, Guttman M, Ang L, Adams V, Furukawa Y, Haycock JW. Kish SJ, et al. Among authors: haycock jw. Neuropsychopharmacology. 2001 May;24(5):561-7. doi: 10.1016/S0893-133X(00)00209-8. Neuropsychopharmacology. 2001. PMID: 11282256

4

Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies?

Kish SJ, Zhong XH, Hornykiewicz O, Haycock JW. Kish SJ, et al. Among authors: haycock jw. Ann Neurol. 1995 Aug;38(2):260-4. doi: 10.1002/ana.410380220. Ann Neurol. 1995. PMID: 7654075

5

Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia.

Furukawa Y, Nygaard TG, Gütlich M, Rajput AH, Pifl C, DiStefano L, Chang LJ, Price K, Shimadzu M, Hornykiewicz O, Haycock JW, Kish SJ. Furukawa Y, et al. Among authors: haycock jw. Neurology. 1999 Sep 22;53(5):1032-41. doi: 10.1212/wnl.53.5.1032. Neurology. 1999. PMID: 10496263

6

Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum.

Haycock JW, Becker L, Ang L, Furukawa Y, Hornykiewicz O, Kish SJ. Haycock JW, et al. J Neurochem. 2003 Nov;87(3):574-85. doi: 10.1046/j.1471-4159.2003.02017.x. J Neurochem. 2003. PMID: 14535941 Free article.

7

Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia.

Furukawa Y, Kapatos G, Haycock JW, Worsley J, Wong H, Kish SJ, Nygaard TG. Furukawa Y, et al. Among authors: haycock jw. Ann Neurol. 2002 May;51(5):637-41. doi: 10.1002/ana.10175. Ann Neurol. 2002. PMID: 12112113

8

Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity.

Lew JY, Garcia-Espana A, Lee KY, Carr KD, Goldstein M, Haycock JW, Meller E. Lew JY, et al. Among authors: haycock jw. Mol Pharmacol. 1999 Feb;55(2):202-9. doi: 10.1124/mol.55.2.202. Mol Pharmacol. 1999. PMID: 9927609

9

Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size.

Pothos EN, Larsen KE, Krantz DE, Liu Y, Haycock JW, Setlik W, Gershon MD, Edwards RH, Sulzer D. Pothos EN, et al. Among authors: haycock jw. J Neurosci. 2000 Oct 1;20(19):7297-306. doi: 10.1523/JNEUROSCI.20-19-07297.2000. J Neurosci. 2000. PMID: 11007887 Free PMC article.

10

Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter.

Jaber M, Dumartin B, Sagné C, Haycock JW, Roubert C, Giros B, Bloch B, Caron MG. Jaber M, et al. Among authors: haycock jw. Eur J Neurosci. 1999 Oct;11(10):3499-511. doi: 10.1046/j.1460-9568.1999.00764.x. Eur J Neurosci. 1999. PMID: 10564358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page